Chronic Myeloid Leukemia Advocacy, Education, and Support Groups

 

You'll be surprised at just how many organizations there are that are devoted to cancer. The following organizations provide a variety of programs, educational materials, and other forms of support for people with chronic myeloid leukemia, their family members, caregivers, and friends. However, remember that this is not an endorsement of these organizations and the information they provide. You should always discuss any questions or concerns you have with your health care provider.

American Cancer Society

http://www.cancer.org

1-800-ACS-2345 (toll-free information line)

1-866-228-4327 for TTY

The American Cancer Society (ACS) is a national organization working to eradicate cancer through research, advocacy, and service.  Among its many services, the ACS has a call center that operates 24 hours a day, seven days a week, to answer questions about cancer and link callers with resources in their communities. 

CancerCare

http://www.cancercare.org

Telephone: 1-800-813-4673

E-mail: info@cancercare.org

CancerCare, founded in 1944, is a national nonprofit organization that provides free, professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs–including counseling, education, financial assistance, and practical help–are provided by trained oncology social workers and are completely free. 

M. D. Anderson Cancer Center
http://www.mdanderson.org
1-800-392-1611 (USA)

Department of Leukemia
http://www.mdanderson.org/diseases/adultleukemia
713-792-7305

Leukemia Insights
http://www.mdanderson.org/publications/insights

The Leukemia Department at M. D. Anderson Cancer Center offers multiple research-based programs with new agents or strategies in ALL.  Their programs are updated on the above websites.

National Cancer Institute

http://www.cancer.gov

1-800-422-6237

TTY: 1-800-332-8615

The NCI is a federal organization and a component of the National Institute of Health. The NCI’s National Cancer Program supports and conducts research and distributes cancer information.  The website includes information about various cancer topics, research information, and cancer statistics. The website also includes a description of the NCI's initiative to eliminate cancer death and suffering by the year 2015.

Oncolink

http://www.oncolink.org

Cancer specialists from the University of Pennsylvania founded Oncolink to provide cancer information to cancer patients, health care professionals, and the general public.  The website includes information about various cancer topics, coping information, and an “Ask the Experts” section.  

The Leukemia and Lymphoma Society

http://www.leukemia-lymphoma.org

1-800-955-4572

This society funds research, education, and services involved with blood cancers.  The website includes blood cancer information, online discussion boards, and information about patient support programs, such as patient education workshops.

This content was last modified on August 11, 2007 .
Latest Cancer News
“Scent” May Aid in Skin Cancer Diagnosis

August 21, 2008 — The concentration of certain molecules called volatile organic compounds (VOCs) given off by a cancer may ultimately contribute to accurate diagnosis of skin cancer. These results were recently presented at the 2008 annual American Chemical Society meeting.

Livial® Reduces Breast Cancer Risk but Increases Stroke Risk

August 21, 2008 — Livial® (tibolone), an agent used to reduce menopausal symptoms as well as bone loss, significantly reduces the risk of breast cancer and prevents bone loss and fractures in older postmenopausal women; however, it doubles the risk of stroke among postmenopausal women. These results were recently published in the New England Journal of Medicine.

Watchful Waiting Versus Radical Prostatectomy: 11-year Follow-up

August 21, 2008 — Researchers affiliated with the Scandinavian Prostatic Cancer Group Study Number 4 have reported the following: “Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.” The details of the 3rd report of this randomized trial appeared in an early online publication in the Journal of the National Cancer Institute on August 11, 2008.

Select news items provided by Reuters Health